Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Metastatic Hormone-sensitive Prostate Cancer (mHSPC) × relugolix × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 12 Leiomyoma 4 Prostate Adenocarcinoma 2 Myofibroma 2 Endometriosis 2 Uterine Neoplasms 1 Uterine Hemorrhage 1 Pregnancy Complications 1 Pathologic Complete Response 1 Neoplasm, Residual 1 Myoma 1 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1 Menorrhagia 1 Adenocarcinoma 1

Interventions

relugolix 1 Androgen Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07216248 2025-10-29

OPTIMAS

University of Utah

Phase 2 Recruiting

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡